Best treatments for peritoneal neoplasms
3 products may treat peritoneal neoplasms. The current highest-rated option is zejula. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 3 drugs we list for peritoneal neoplasms, none are yet flagged as generics in our price data. 1 of 3 carry a safety score of 72 out of 100. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for peritoneal neoplasms — so confirm the right choice with your prescriber.
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Tablet | — | No data | — | View → | |
| 2 | Not yet rated | Prescription | Injectable | — | No data | — | View → | |
| 3 | Not yet rated | Prescription | Kit | — | No data | — | View → |
Full ranking · 3 treatments
zejula
PrescriptionFDA-sourced
Zejula (Niraparib Tosylate) is a medication used to treat Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms.
Price varies
elahere
Boxed warningPrescriptionFDA-sourced
Elahere (Mirvetuximab Soravtansine-Gynx) is a medication used to treat Ovarian Epithelial Carcinoma, Fallopian Tube Neoplasms, Peritoneal Neoplasms.
Price varies
lifyorli (copackaged)
PrescriptionFDA-sourced
Lifyorli (Copackaged) (Relacorilant) is a medication used to treat Ovarian Epithelial Carcinoma, Fallopian Tube Neoplasms, Peritoneal Neoplasms.
Price varies
Frequently asked
- What treats peritoneal neoplasms?
- Our catalog lists 3 products that may treat peritoneal neoplasms, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is zejula.
- What is the best-rated treatment for peritoneal neoplasms?
- By our independent recall-safety rating — not an efficacy measure — zejula ranks highest among the products we list for peritoneal neoplasms. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Where this ranking comes from
Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.
- FDA Drug Enforcement (recall) database — the recall history behind the safety score
- DailyMed (NIH National Library of Medicine) — the FDA labels we quote for uses, dosing and warnings
- Drugs@FDA — approvals, strengths and marketing status